Brenda Mann's most recent trade in Kiora Pharmaceuticals Inc was a trade of 62 Common Stock done at an average price of $2.0 . Disclosure was reported to the exchange on Nov. 2, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiora Pharma Inc | Brenda Mann | VP of Research & Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share. | 02 Nov 2021 | 62 | 15,136 (0%) | 0% | 2.0 | 123 | Common Stock |
| Kiora Pharma Inc | Brenda Mann | VP of Research & Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. | 04 Oct 2021 | 62 | 15,198 (0%) | 0% | 2.0 | 125 | Common Stock |